Tekcapital’s Salarius secures deal with Hanks Brokerage
, announced on Friday that its 97.5% owned Salarius secured a deal with national food ingredient broker Hanks Brokerage to assist in the sale of Microsalt® to snack food companies in the southwestern United States.
Founded in 1979, Hanks Brokerage represents ingredients and finished products to food manufacturers, restaurant chains and food service distributors.
"Hanks Brokerage is proud to partner with Salarius, to provide a great solution to meet the challenges of sodium reduction in formulations" says Greg Hanks, President of Hanks Brokerage. “We prefer adding product lines such as Microsalt® to our partner listing because it provides a new and innovative solution to a problem in the industry and because of the great team behind the product.”
“We look forward to growing with Salarius and having a long-term partnership in the industry"
Salarius’s MicroSalt® is a proprietary salt made with micron-size salt particles that dissolve in the mouth significantly faster than regular salt, delivering an increased sensation of saltiness with approximately 50% less sodium.
As a result of deals like this, and attendance of trade shows and events, Tekcapital told investors that over 25 potential customers are in the process of testing and evaluating the applicability of Microsalt® for their snacks and product lines.
"We are very excited about our partnership with Hanks Brokerage and working with their team of sales professionals to expand brand awareness and accelerate sales of Microsalt®, says Victor Hugo Manzanilla, CEO of Salarius.
“Our partnership is a win-win-win as we are offering their customers a unique, on-trend, innovative ingredient that will also help consumers lower their sodium intake."
Dr Clifford Gross, Executive Chairman at Tekcapital, commented: "We are glad to see the expansion of Salarius' go to market effort to additional geographical markets in the United States.
Follow News & Updates from Tekcapital here:
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.